Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

European approval for Kyntheum for moderate to severe plaque psoriasis

July 20, 2017

FDA designates StrataGraft a regenerative medicine advanced therapy

July 19, 2017

Abeona receives guidance on phase III trial of EB-101 for epidermolysis bullosa

July 19, 2017

NICE final guidance recommends Humira, Enbrel and Stelara for plaque psoriasis in children

July 18, 2017

Novartis has 5-year data for Cosentyx in plaque psoriasis

July 18, 2017

FDA approves Tremfya for moderate to severe plaque psoriasis

July 14, 2017

FDA awards orphan drug status to Principia Biopharma's PRN-1008

July 12, 2017

FDA clinical hold on Concert Pharmaceuticals' trial of CTP-543 lifted

July 11, 2017

Novan presents new data on SB-204 in adolescents

July 10, 2017

Cytovation raises funds to advance CyPep-1

July 4, 2017

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...